For K-RAS negative malignant CITNs, 3/8 (37.5%) had central lymph node metastasis, 1/8 (12.5%) had lateral lymph node metastasis, while none had ETE or distant metastasis. The gene discussed is KRAS; the disease is metastatic malignant neoplasm in the lymph nodes.